Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 371 of 6351
-
New stent could save limbs in critical leg artery disease
Disease control Not yet recruitingThe purpose of this trial is to evaluate the safety and efficacy of the Drug Eluting Temporary Spur Stent System compared to PTA. The Drug Eluting Temporary Spur Stent System is intended for use as a primary treatment in the infrapopliteal arteries for the treatment of de novo o…
Sponsor: ReFlow Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a common blood thinner replace warfarin for LVAD patients?
Disease control Not yet recruitingThis study is being done to learn the safety and efficacy of a new anticoagulant therapy with apixaban as compared to warfarin to prevent thrombotic events while protecting from bleeding complications in patients with advanced heart failure who are chronically supported by a Hear…
Phase 3 • Sponsor: Columbia University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
One-Stop hepatitis c care could save thousands of lives
Disease control Not yet recruitingThis is a two-arm cluster randomized control trial to evaluate the effectiveness of a single-visit point-of-care (POC) test and treat bundle (intervention arm) compared to the current standard-of-care (SOC, control arm). 1:1 randomization occurs at the site level.
Phase 4 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Quick blood tests could save newborns from sepsis
Diagnosis Not yet recruitingNeonatal sepsis is a leading cause of illness and death in Neonatal Intensive Care Units (NICUs). Diagnosing it quickly is challenging because the early signs often overlap with other common newborn health issues. While a blood culture is the most accurate way to confirm an infec…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
New radiation technique aims to shield airways and preserve lung function
Symptom relief Not yet recruitingDecreased respiratory function is a common side effect experienced by non-small cell lung cancer (NSCLC) patients who receive radiation therapy. In current clinical practice when treating cancerous lesions in the lung, it is not standard to explicitly try and avoid excessive radi…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New biologic aims to tackle stubborn high triglycerides
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase 3 trial for adults with severe hypertriglyceridemia whose lipid levels remain uncontrolled under standard Icosapent Ethyl background treatment plus lifestyle management. Eligible participants complete a scr…
Phase 3 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Protein zapper: new drug targets breast cancer from the inside
Disease control Not yet recruitingThe trial comprises Phase I dose escalation/expansion and Phase II combination therapy. Using a multicenter, open-label, non-randomized design, breast cancer patients will receive TQB3126 to assess its safety, tolerability, pharmacokinetics and preliminary efficacy.
Phase 1/2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a four-drug cocktail shrink hard-to-treat colorectal cancer?
Disease control Not yet recruitingPrimary endpoint: objective response rate Secondary endpoints: PFS, OS and adverse events
Phase 2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a gentle brain washout save newborns from a lifetime shunt?
Disease control Not yet recruitingNeonatal intraventricular hemorrhage (IVH) is a major cause of morbidity and mortality in premature infants and is frequently associated with post-hemorrhagic ventricular dilatation (PHVD) and hydrocephalus. Neuroendoscopic lavage (NEL) is a minimally invasive technique that allo…
Sponsor: Assiut University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Zapping pain without drugs: brain stimulation put to the test for nerve pain
Symptom relief Not yet recruitingThis study employs temporal interference stimulation (tTIS) to investigate the analgesic effects of tTIS on neuropathic pain and monitor changes in neural plasticity, and explore the dynamic relationship between analgesic efficacy and neural plasticity, thereby providing new stra…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Ear stimulation may boost brain rewiring in babies with brain injury
Disease control Not yet recruitingThis study is for infants and toddlers between 8 and 24 months old who use one arm and/or hand differently following a perinatal brain injury. This is a time when investigators think they can best help improve how the brain controls movement. Investigators are testing whether the…
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a Dual-Action antibody outsmart advanced solid tumors?
Disease control Not yet recruitingThis study is an open-label, multicenter, dose-escalation and dose-expansion, non-randomized phase I clinical study evaluating the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally adva…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
Disease control Recruiting nowStandard Behavioral Parent Training (BPT) is often less effective for parents experiencing depression. As such, the Addressing Depression and Positive Parenting Techniques (ADAPT) intervention is a novel BPT tailored to address the unique emotional and cognitive needs of depresse…
Sponsor: University of Toronto • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new drug shrink Hard-to-Treat tumors?
Disease control Not yet recruitingThis is a Phase I, multicenter, open-label, single-arm and first-in-human clinical study of BR113 for injection. The study objectives are to evaluate the safety, tolerability, pharmacokinetic profile, anti-tumor activity and immunogenicity of BR113 for injection in patients with …
Phase 1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a spice and a mindset shift ease diabetic nerve pain?
Disease control Not yet recruitingThis randomized controlled trial aims to evaluate the therapeutic effects of pure Ceylon cinnamon (Cinnamomum verum) supplementation combined with a structured self-efficacy-based educational program on glycemic control, lipid profiles, and neuropathic pain in adult patients with…
Sponsor: Jerash Private University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a mushroom boost your brain? Lion's mane put to the test
Symptom relief Not yet recruitingThe primary purpose of the research is to evaluate in healthy adults the time course effects of varying dosages of Lion's mane mushroom on attention and mood.
Sponsor: Northumbria University • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a new infusion drug shrink Hard-to-Treat tumors?
Disease control Not yet recruitingThis is an open-label, multicenter, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of BL-ARC002 Injection in patients with locally advanced or metastatic solid tumors.
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
AI tailors swallowing therapy: a new hope for dysphagia?
Disease control Not yet recruitingThe goal of this clinical study is to learn if an artificial intelligence (AI)-assisted swallowing rehabilitation program can improve swallowing function in adults with dysphagia. It will also learn whether this approach can better detect aspiration (food or liquid entering the a…
Sponsor: National Research Center for Rehabilitation Technical Aids • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can gentle air puffs to the throat reboot swallowing after stroke?
Symptom relief Not yet recruitingThis randomized, double-blind, sham-controlled clinical trial will investigate the effects and potential neural mechanisms of pharyngeal air-pulse sensory stimulation in patients with post-stroke dysphagia. A total of 80 participants with swallowing impairment after stroke will b…
Sponsor: First People's Hospital of Foshan • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Team-Based care may cut hospital readmissions for a common heart failure
Disease control Not yet recruitingHeart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure cases and is associated with frequent hospitalizations, poor quality of life, and limited effective treatment options. Fragmented, single-discipline care often fails to add…
Sponsor: Chimei Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC